**Question:** Which of the following is a serious adverse effect seen with bisphosphonates:

A. Osteonecrosis of the jaw (ONJ)
B. Increased risk of fracture
C. Gastrointestinal issues (GI)
D. Skin rash

**Core Concept:** Bisphosphonates are a class of medications commonly used for the treatment of osteoporosis and other bone-related conditions. They work by inhibiting osteoclast activity, reducing bone resorption, and promoting bone formation.

**Why the Correct Answer is Right:** Osteonecrosis of the jaw (ONJ) is a serious adverse effect associated with bisphosphonate use. ONJ occurs when bone necrosis occurs in the jaw due to a combination of factors, including prolonged bisphosphonate therapy, dental procedures, and impaired wound healing. It is a well-documented complication seen primarily in patients receiving high-dose intravenous bisphosphonates for cancer therapy.

**Why Each Wrong Option is Incorrect:**

- **Option B (Increased risk of fracture):** Although bisphosphonates increase bone density and decrease the risk of fractures, they do not eliminate this risk entirely. The correct answer is not incorrect but provides an incomplete understanding of the potential risks associated with bisphosphonate use.

- **Option C (GI issues):** While some GI symptoms may occur in the early phase of therapy, serious gastrointestinal adverse effects are relatively rare. The correct answer does not specify the serious complication discussed with the correct answer.

- **Option D (Skin rash):** Although skin rashes can occur rarely, they are not the main severe adverse effect associated with bisphosphonate therapy. The correct answer is not the focus of the question.

**Clinical Pearl:** Osteonecrosis of the jaw is a serious and potentially irreversible adverse effect seen with bisphosphonate use, particularly in high-dose intravenous therapy for cancer treatment. It is essential for healthcare professionals to be aware of this potential complication when prescribing or discussing bisphosphonate therapy with patients.

**Correct Answer:** **Option A (Osteonecrosis of the jaw):** This is the correct answer, highlighting a severe adverse effect associated with bisphosphonate use, particularly in intravenous forms for cancer treatment. Bisphosphonate-induced ONJ is a significant concern in clinical practice, and healthcare professionals should emphasize this risk to patients undergoing such therapy.